Business Development

Manhattan Pharmaceuticals is committed to strategic growth through targeted product acquisition.  The company actively pursues product/program purchase, in-licensing, and co-development opportunities that are aligned with its internal areas of expertise and offer significant value to its pipeline.

 

Please direct Business Development inquiries to:

Douglas Abel, President & CEO
Manhattan Pharmaceuticals, Inc.
48 Wall Street, Suite 1100
New York, NY  10005
212.582.3950 phone
212.582.3957 fax